Bio-Rad Laboratories | BIO - Cash And Equivalent


Bio-Rad Laboratories reported $529.8M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Abbott USD 8.52B 1.01B Dec/2025
Agilent USD 1.76B 31M Dec/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Bio Techne USD 172.88M 27.92M Dec/2025
Bio-Rad Laboratories USD 529.8M 134M Dec/2025
Bruker USD 293.1M 201.1M Sep/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Danaher USD 4.62B 3.09B Dec/2025
General Electric Aerospace USD 12.39B 109M Dec/2025
Hologic USD 2.17B 208.5M Dec/2025
Illumina USD 1.42B 368M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Laboratory Of America USD 532.3M 65.8M Dec/2025
Merck USD 18.17B 10.16B Sep/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Myriad Genetics USD 149.6M 4.2M Dec/2025
OraSure Technologies USD 199.28M 17.2M Dec/2025
Pacific Biosciences Of California USD 279.51M 223.04M Dec/2025
Quest Diagnostics USD 420M 12M Dec/2025
Repligen USD 566.02M 182.73M Dec/2025
Revvity USD 919.86M 11.53M Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
Siemens EUR 14.5B 146M Sep/2025
Standard Biotools USD 118.21M 11.2M Dec/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Tosoh JPY 133.1B 10.44B Sep/2025
Waters USD 587.83M 128.71M Dec/2025